Alma connects to PatientsLikeMe chronic patients

Diving deeper into

Alma

Company Report
The December 2024 integration with PatientsLikeMe connects Alma's provider network to over 1 million members managing chronic conditions, reaching a high-acuity patient segment that has historically underutilized behavioral health services.
Analyzed 7 sources

This partnership matters because it gives Alma a cheaper and more clinically valuable patient acquisition channel than broad consumer marketing. PatientsLikeMe already aggregates people actively tracking chronic illnesses, symptoms, and treatment journeys, so Alma is not just getting more traffic, it is getting patients with higher behavioral health need and more reasons to stay in care over time. That fits Alma’s model of recurring therapy, psychiatry expansion, and insurer reimbursed visits.

  • PatientsLikeMe is built around condition specific communities, symptom tracking, treatment histories, and patient education. Its provider directory also routes members to licensed mental health therapists. That means Alma is plugging into an existing workflow where members are already looking for next steps in care, not starting from a cold search.
  • For Alma, chronic condition members are especially attractive because therapy is rarely a one visit interaction. Alma makes money from a $125 monthly provider fee plus a share of insurance reimbursements, so patients who book recurring in network sessions and may later add psychiatry are worth materially more than one off leads.
  • This also strengthens Alma against other therapist enablement networks. Headway wins providers with no membership fee and fast booking, while Rula leans on heavy patient acquisition and a pure take rate model. Alma’s PatientsLikeMe tie in gives it a differentiated referral source tied to medically complex populations and payer priorities around whole person care.

Going forward, the real upside is turning Alma from a therapist marketplace into a behavioral health layer inside chronic care. If Alma can convert condition communities into steady therapy and psychiatry utilization, it becomes more valuable to payers, EAPs, and disease focused partners that need behavioral support embedded alongside medical care.